Trademark: 97125105
Word
AIRNECFLU
Status
Dead
Status Code
606
Status Date
Monday, April 1, 2024
Serial Number
97125105
Mark Type
4000
Filing Date
Monday, November 15, 2021
Published for Opposition
Tuesday, July 4, 2023
Abandoned Date
Monday, April 1, 2024

Trademark Owner History
SyneuRx International (Taiwan) Corp. - Owner At Publication

Classifications
5 Antiviral drugs; antibiotics; antibiotics for animals; chemical reagent for medical purposes; chemical reagent for veterinary purposes; germicides for animals; germicides; biocides for medical purposes; germicide for human use; biocides for veterinary purposes; medicines for human purposes namely, for treatment of virus infection, neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, hyperactivity, anxiety, bipolar disorder, and other central nervous system disorders; medicines for human purposes namely, for improving basic behavioral functioning, suicidal ideation and behavior, sensorimotor gating, pain threshold, memory and cognitive functioning and loss weight; sedatives; nervines for pharmaceutical or medical purposes, namely, for treating attention deficit hyperactivity disorder (ADHD), schizophrenia, pain, depression, bipolar disorder, eating disorder, addiction disorder, personality disorder, psychotic disorder, tic disorder, post-traumatic stress disorder, anxiety, social anxiety disorder, panic disorder, autism, Asperger's disorder, obsessive-compulsive disorder (OCD), learning disorder, Tourette's syndrome, mild cognitive disorder (MCI), benign forgetfulness, closed head injury, dementia, vascular dementia, Alzheimer's disorder, frontotemporal dementia, Parkinson's disorder, Huntington's disease, nocturnal enuresis, blepharospasm, non-epileptic seizure, premenstrual syndrome, and amyotrophic lateral sclerosis (ALS); gases for pharmaceutical or medical purposes, namely, for treating attention deficit hyperactivity disorder (ADHD), schizophrenia, pain, depression, bipolar disorder, eating disorder, addiction disorder, personality disorder, psychotic disorder, tic disorder, post-traumatic stress disorder, anxiety, social anxiety disorder, panic disorder, autism, Asperger's disorder, obsessive-compulsive disorder (OCD), learning disorder, Tourette's syndrome, mild cognitive disorder (MCI), benign forgetfulness, closed head injury, dementia, vascular dementia, Alzheimer's disorder, frontotemporal dementia, Parkinson's disorder, Huntington's disease, nocturnal enuresis, blepharospasm, non-epileptic seizure, premenstrual syndrome, and amyotrophic lateral sclerosis (ALS);nasal spray for treating respiratory tract infections caused by viruses or bacteria; oral spray for treating respiratory tract infections caused by viruses or bacteria

Trademark Events
Apr 1, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 1, 2024
Abandonment - No Use Statement Filed
Aug 29, 2023
Noa E-Mailed - Sou Required From Applicant
Jul 4, 2023
Official Gazette Publication Confirmation E-Mailed
Jul 4, 2023
Published For Opposition
Jun 14, 2023
Notification Of Notice Of Publication E-Mailed
Jun 1, 2023
Approved For Pub - Principal Register
May 2, 2023
Teas/Email Correspondence Entered
May 2, 2023
Correspondence Received In Law Office
May 2, 2023
Teas Request For Reconsideration Received
Feb 11, 2023
Notification Of Final Refusal Emailed
Feb 11, 2023
Final Refusal E-Mailed
Feb 11, 2023
Final Refusal Written
Dec 29, 2022
Teas/Email Correspondence Entered
Dec 29, 2022
Correspondence Received In Law Office
Dec 29, 2022
Teas Response To Office Action Received
Aug 25, 2022
Notification Of Non-Final Action E-Mailed
Aug 25, 2022
Non-Final Action E-Mailed
Aug 25, 2022
Non-Final Action Written
Aug 25, 2022
Assigned To Examiner
Nov 19, 2021
New Application Office Supplied Data Entered
Nov 18, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24